NeuroClimax Gold™ (Simple) – Kinetin Nasal Spray | 1-Month Supply

NeuroClimax Gold™ (Simple) — A Streamlined Kinetin Formulation

One active ingredient. A distinct scientific foundation. A simpler NeuroClimax formulation.

NeuroClimax Gold™ (Simple) is a proprietary intranasal nootropic formulation developed by CNS Curative Technologies LLC. It features kinetin as its sole active ingredient, distinguishing it from the company's multi-ingredient NeuroClimax formulations.

Designed as a streamlined alternative within the NeuroClimax product family, Gold (Simple) provides a single-active-ingredient formulation for customers who want to understand its composition and scientific rationale before exploring more complex combinations.

Its development draws on scientific investigations involving mitochondrial biology, PINK1-related signaling, and neuronal function.

Important distinction: Research on individual compounds and biological mechanisms does not establish that the finished formulation improves cognitive performance or produces specific clinical outcomes.

What Makes NeuroClimax Gold™ (Simple) Different?

The defining characteristic of NeuroClimax Gold (Simple) is its streamlined composition.

• Single active ingredient: Kinetin.
• Scientific focus: Research involving PINK1-associated mitochondrial signaling and related cellular processes.
• Delivery format: Proprietary intranasal spray formulation.
• Product quantity: One-month supply, as described by CNS Curative.
• Formulation distinction: Contains fewer active ingredients than NeuroClimax Gold (Max).
• Manufacturer: CNS Curative Technologies LLC.

Gold (Simple) offers a different formulation composition, not a demonstrated clinical advantage over the other NeuroClimax products.

The Science Behind Kinetin

Kinetin and Mitochondrial Biology

Kinetin is a compound investigated in biochemical and preclinical research involving mitochondrial processes and cellular signaling.

One area of scientific interest is PTEN-induced kinase 1 (PINK1), a protein involved in mitochondrial quality control and cellular responses to mitochondrial damage.

Published preclinical studies have explored kinetin-related compounds and their interactions with PINK1-associated pathways. These investigations contribute to the scientific rationale behind CNS Curative's interest in kinetin.

However, the biological activity observed in laboratory models cannot automatically be attributed to the finished NeuroClimax Gold (Simple) product.

Neuronal Function and Research Context

Healthy neuronal function involves several interconnected biological processes, including:

• Mitochondrial energy metabolism.
• Cellular responses to oxidative stress.
• Neuronal signaling and cellular maintenance.
• Synaptic plasticity.
• Neurotrophic signaling pathways.

Brain-derived neurotrophic factor (BDNF), for example, is a protein involved in neuronal development, survival, and synaptic plasticity.

Scientific investigations have examined relationships between mitochondrial function, oxidative stress, BDNF-related signaling, and neuronal biology.

These research areas provide background for the formulation's development. They should not be interpreted as demonstrated effects of NeuroClimax Gold (Simple) in humans.

NeuroClimax Gold™ (Simple) vs. Gold™ (Max)

CNS Curative offers two Gold formulations with different active-ingredient compositions.

NeuroClimax Gold™ (Simple)

One active ingredient:

• Kinetin — investigated in preclinical research involving PINK1-related mitochondrial signaling.

Gold (Simple) provides a single-active-ingredient composition.

NeuroClimax Gold™ (Max)

Three active ingredients:

• Kinetin: Investigated in research involving mitochondrial biology and PINK1-related signaling.
• Noopept: Studied in experimental research involving neuronal signaling, learning, and memory-related processes.
• Centrophenoxine: Investigated in research involving cholinergic function and cognitive processes.

Gold (Max) combines multiple compounds with different research backgrounds, whereas Gold (Simple) contains only kinetin as its active ingredient.

Which formulation should you explore?

If your priority is understanding a single-active-ingredient composition, review Gold (Simple). If you want to examine a broader ingredient combination, explore Gold (Max).

This comparison describes formulation differences, not proven differences in effectiveness or safety.

Explore NeuroClimax Gold™ (Max)

Understanding the Intranasal Formulation

NeuroClimax Gold (Simple) uses an intranasal administration format rather than conventional oral delivery.

Intranasal delivery is an established area of pharmaceutical research because the nasal cavity provides an alternative route for administering certain compounds.

However, the effectiveness, absorption, distribution, and safety of a particular intranasal formulation depend on its complete composition and supporting testing.

The use of an intranasal delivery system alone does not demonstrate superior absorption, improved brain delivery, or clinical effectiveness.

Additional Formulation Components

According to the original CNS Curative product information, inactive formulation components may include:

• Sterile phosphate-buffered saline.
• Cyclodextrins.
• Preservative agents.
• Solubilizing agents.
• Soothing or formulation-stabilizing excipients.

Please note: This is a description of possible formulation components, not a verified complete ingredient declaration. Customers should consult the current product label or contact CNS Curative Technologies for the exact composition.

Manufacturing and Product Information

NeuroClimax™ products are developed and manufactured by CNS Curative Technologies LLC.

According to the company's published product information, its manufacturing processes involve controlled sterile cleanroom conditions.

Customers seeking additional information about product specifications, manufacturing documentation, quality testing, storage requirements, or formulation ingredients can contact the company directly.

Manufacturing statements should be considered alongside the supporting documentation for the relevant product and production batch.

Scientific Research and References

The NeuroClimax scientific background draws on published investigations involving neuronal signaling, mitochondrial function, oxidative stress, and selected nootropic compounds.

The following references are retained from CNS Curative's existing product information:

• Costa, A., et al. Frontiers in Behavioral Neuroscience. 2015;9:253.
• Dagda, R.K., & Das Banerjee, T. Reviews in the Neurosciences. 2015;26(3):359–370.
• Hertz, N.T., et al. Cell. 2013;154(4):737–747.
• Soman, S.K., et al. Journal of Neuroscience Research. 2021;99(9):2134–2155.
• Ostrovskaya, R.U., et al. Bulletin of Experimental Biology and Medicine. 2008;146(3):334–337.
• Marcer, D., & Hopkins, S.M. Age and Ageing. 1977;6(2):123–131.

These references concern scientific research involving biological pathways and individual compounds. They do not, by themselves, establish the clinical safety or effectiveness of the finished NeuroClimax Gold (Simple) formulation.

For additional information about the company's research activities, visit CNS Curative Technologies.

Intellectual Property and Product Development

CNS Curative Technologies identifies the following provisional patent application in its published product documentation:

• U.S. Provisional Patent Application: 63/897,520.
• Application title: Treatment of Cognitive Decline and Fatigue with Intranasal Nootropic Formulations.
• First named inventor: Raul Y. Dagda.
• Applicant: CNS Curative Technologies LLC.
• Reference: FHW081752.

This information describes the company's reported intellectual property filing and does not represent a statement that a patent has been granted or that the product has received regulatory approval.

NeuroClimax™ is identified by CNS Curative Technologies LLC as its trademark.

Before Ordering NeuroClimax Gold™ (Simple)

Review the product's complete ingredient information, current labeling, directions, warnings, and purchase terms before making a decision.

If you have questions about the formulation, ingredient concentrations, product suitability, or supporting documentation, contact CNS Curative Technologies before ordering. Seek advice from an appropriately qualified healthcare professional regarding individual medical considerations.

The product's current availability, pricing, and purchasing options are displayed separately on this page.

For ordering and customer-support information, visit:

• Contact CNS Curative Technologies
• Shipping Information
• Returns and Refund Information

About CNS Curative Technologies

CNS Curative Technologies LLC
300 East 2nd Street
15th Floor, Suite 1512
Reno, Nevada 89501
USA

Phone: 775-376-0613
Email: contact@cnscurative.com

Company website: www.cnscurative.com

Important Scientific and Safety Information

The scientific information presented here is based primarily on mechanistic, experimental, and preclinical research involving individual compounds and biological pathways.

These findings do not establish the clinical safety, effectiveness, appropriate dosing, or therapeutic benefits of the finished NeuroClimax Gold™ (Simple) formulation.

Product-specific regulatory status, safety documentation, labeling, and medical claims should be confirmed with CNS Curative Technologies and appropriately qualified regulatory professionals.